145 related articles for article (PubMed ID: 22293605)
1. Neuroprotection by urokinase plasminogen activator in the hippocampus.
Cho E; Lee KJ; Seo JW; Byun CJ; Chung SJ; Suh DC; Carmeliet P; Koh JY; Kim JS; Lee JY
Neurobiol Dis; 2012 Apr; 46(1):215-24. PubMed ID: 22293605
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus.
Lahtinen L; Ndode-Ekane XE; Barinka F; Akamine Y; Esmaeili MH; Rantala J; Pitkänen A
Neurobiol Dis; 2010 Mar; 37(3):692-703. PubMed ID: 20026272
[TBL] [Abstract][Full Text] [Related]
3. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus.
Tsirka SE; Rogove AD; Bugge TH; Degen JL; Strickland S
J Neurosci; 1997 Jan; 17(2):543-52. PubMed ID: 8987777
[TBL] [Abstract][Full Text] [Related]
4. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.
Flavin MP; Zhao G
J Neurosci Res; 2001 Mar; 63(5):388-94. PubMed ID: 11223913
[TBL] [Abstract][Full Text] [Related]
6. DNA damage and nonhomologous end joining in excitotoxicity: neuroprotective role of DNA-PKcs in kainic acid-induced seizures.
Neema M; Navarro-Quiroga I; Chechlacz M; Gilliams-Francis K; Liu J; Lamonica K; Lin SL; Naegele JR
Hippocampus; 2005; 15(8):1057-71. PubMed ID: 16216017
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
[TBL] [Abstract][Full Text] [Related]
8. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.
Tsirka SE; Gualandris A; Amaral DG; Strickland S
Nature; 1995 Sep; 377(6547):340-4. PubMed ID: 7566088
[TBL] [Abstract][Full Text] [Related]
9. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activators promote excitotoxicity-induced retinal damage.
Mali RS; Cheng M; Chintala SK
FASEB J; 2005 Aug; 19(10):1280-9. PubMed ID: 16051695
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator is not required for kainate-induced motoneuron death in vitro.
Vandenberghe W; Van Den Bosch L; Robberecht W
Neuroreport; 1998 Aug; 9(12):2791-6. PubMed ID: 9760122
[TBL] [Abstract][Full Text] [Related]
14. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator.
Kim YH; Park JH; Hong SH; Koh JY
Science; 1999 Apr; 284(5414):647-50. PubMed ID: 10213688
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
[TBL] [Abstract][Full Text] [Related]
16. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
17. AIT-082 is neuroprotective against kainate-induced neuronal injury in rats.
Di Iorio P; Virgilio A; Giuliani P; Ballerini P; Vianale G; Middlemiss PJ; Rathbone MP; Ciccarelli R
Exp Neurol; 2001 Jun; 169(2):392-9. PubMed ID: 11358452
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
[TBL] [Abstract][Full Text] [Related]
19. Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin.
Sumanont Y; Murakami Y; Tohda M; Vajragupta O; Watanabe H; Matsumoto K
Life Sci; 2006 Mar; 78(16):1884-91. PubMed ID: 16266725
[TBL] [Abstract][Full Text] [Related]
20. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.
Ananth C; Gopalakrishnakone P; Kaur C
Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
